How do you approach CNS prophylaxis in patients with DLBCL?

Would you follow an algorithm such as the one proposed by Hall et al., PMID 29940062?

How do you decide between intrathecal chemotherapy vs systemic therapy with HD-MTX?

Answer from: Radiation Oncologist at Community Practice

I think the NCCN-CNS-IPI based on the German data is a reasonable place to start when it comes to making decisions regarding CNS prophylaxis. We typically do IT MTX for patients on the lower end of the risk spectrum and high-dose IV MTX for patients on the higher end of the risk spectrum.

Comments

Medical Oncologist at University of Utah
Any way we can get an update on this with recent d...

Medical Oncologist at Huntsman Cancer Institute, University of Utah
@Austin Poole - thanks for inquiring about the art...

Please select the option that best describes you:

How do you approach CNS prophylaxis in patients with DLBCL?

Related Questions